Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region

CompletedOBSERVATIONAL

Enrollment

160

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

July 20, 2023

Study Completion Date

July 20, 2023

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG

Dimethyl Fumarate (DMF)

Gastro-resistant Hard Capsules. Each capsule contains 240mg or 120mg Dimethyl Fumarate

Trial Locations (6)

CHU Frantz FANON, Blida

Nedir Mohamed Hospital, Tizi Ouzou

New University Hospital, Alexandria

Demerdash hospital (Ain Shams University), Cairo

Private Clinic, Cairo

King Abdullah University Hospital (KAUH), Ar Ramtha